Table 4

HRs for mortality according to colon subsites (using sigmoid colon as reference) among 23 487 patients, Denmark 2001–2011

 CaecumAscending colonHepatic flexureTransverse colonSplenic flexureDescending colonSigmoid colon
HR (95% CI)HR (95% CI)HR (95% CI)HR (95% CI)HR (95% CI)HR (95% CI)HR (95% CI)
Females
 Years 1–21.25 (1.16 to 1.35)1.03 (0.94 to 1.13)1.28 (1.14 to 1.43)1.44 (1.30 to 1.59)1.75 (1.54 to 2.00)1.32 (1.13 to 1.53)1.0 (reference)
 Years 3–50.97 (0.84 to 1.13)0.70 (0.58 to 0.85)0.82 (0.65 to 1.05)0.97 (0.78 to 1.20)0.89 (0.65 to 1.21)1.18 (0.89 to 1.56)1.0 (reference)
Males
 Years 1–21.34 (1.23 to 1.45)1.16 (1.05 to 1.29)1.50 (1.34 to 1.67)1.55 (1.39 to 1.73)1.71 (1.51 to 1.95)1.18 (1.02 to 1.37)1.0 (reference)
 Years 3–51.10 (0.95 to 1.28)0.78 (0.64 to 0.94)0.83 (0.66 to 1.05)1.01 (0.81 to 1.25)1.17 (0.91 to 1.51)0.94 (0.73 to 1.22)1.0 (reference)
  • Cox proportional hazard models adjusted for age. Further adjustment for ASA score, number of harvested lymph nodes, lymph nodes with metastases and UICC stage had minor impact on estimates (please see the text).

  • ASA, American Society of Anaesthesiologists; UICC, Union for International Cancer Control.